Future-proofing children’s health through immunisation  

The decline of the 2022 Italian mpox epidemic: Role of behavior changes and control strategies

Bridging the gap to ensure equitable treatment options for children and pregnant people 

The socioeconomic impact of the COVID-19 lockdown on families affected by childhood respiratory illnesses in Cape Town, South Africa

New animation clears up GDPR for research participants

Lower respiratory tract infection admissions and deaths among children under 5 years in public sector facilities in the Western Cape Province, South Africa, before and during the COVID-19 pandemic (2019 – 2021)

SARS-CoV-2 Infection and Hospitalization in Immunocompromised Children: A Population-Based Study

Pharmacokinetics of once-daily DTG/3TC FDC in children living with HIV: D3/PENTA21 sub-study

HIV-1 Reservoir Dynamics in Children With Early Treated, Perinatally-Acquired HIV: Does Sex Matter?

SARS-CoV-2 Infection and Hospitalization in Immunocompromised Children: A Population-Based Study

Risk of SARS-CoV-2 Reinfection in Children Within the 12 Months Following Mild COVID-19: Insights From a Survey Study

The Penta Foundation achieves Gender Equality Certification: Leading the way in Italy for a more inclusive future

Outcomes Following Prenatal Exposure to Raltegravir: A Multi-Cohort European Study

ODYSSEY 192-week follow-up evidences superior efficacy of DTG for children on first/second-line ART

Causes of death after early ART in infants living with HIV from 3 sub-Saharan African countries

An efficient envelope genotypic assay to identify bNab susceptibility in infants with HIV

1 in 5 sub-Saharan infants switches from undetectable to detectable HIV viral load during follow-up  

The development of the Belgian paediatric clinical trial network